QuantLogix ← ULTA scorecard
📅 ULTA Earnings Preview
Ulta Beauty, Inc. Common Stock
Next report (est.)
02/01/2027
Countdown
142 days
EPS growth YoY
-2.2%
Revenue growth YoY
+6.6%
Implied vs actual — last 7 reports
ReportOptions impliedActual moveMarket was
08/27/2026 ±3.0% -0.6% over-priced
06/02/2026 ±3.1% -1.2% over-priced
08/28/2025 ±1.9% -0.6% over-priced
05/29/2025 ±2.5% +1.1% over-priced
12/05/2024 ±3.4% -1.7% over-priced
08/29/2024 ±2.4% +0.2% over-priced
11/30/2023 ±1.7% +1.4% over-priced
Across these reports, options implied an average ±2.5% move vs an actual average of 1.0% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2027 $6.55 $3.0B $282M
Q1 FY2027 $7.74 $3.2B $340M
Q4 FY2026 $0 $0
Q2 FY2026 $5.78 $2.8B $261M
Analyst posture
Buy / Strong Buy
25
Hold
8
Sell
1
Stable: +0 net change 30d
Live 5-factor engine read: Neutral · 45/100 Full scorecard →
🤖 Pro runs a 10-agent AI debate on ULTA before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Ulta Beauty, Inc. Common Stock (ULTA) reports in 142 days, with the next report estimated for 02/01/2027. Across the last 7 reports, options priced an average ±2.5% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced ULTA's earnings risk. Fundamentals into the print: EPS down 2.2% year-over-year, revenue up 6.6%. QuantLogix's live 5-factor engine currently reads ULTA as a neutral at 45/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →